AbCellera Biologics(ABCL) - 2023 Q2 - Earnings Call Presentation

Q2 2023 BUSINESS UPDATE ARELLECBA AUGUST 3, 2023 © DISCLAIMER This presentation contains forward-looking statements, including These statements involve risks, uncertainties and other factors that may ETADPU statements made pursuant to the safe harbor provisions of the Private cause actual results, levels of activity, performance, or achievements to be Securities Litigation Reform Act of 1995. The forward-looking statements materially different from the information expressed or implied by these are based on ...